#United States #Clinical Trials #Portland #Alzheimer's Research #Headlands Research

Celebrating a Milestone

In 2026, Headlands Research - Summit Portland proudly marks its 50th anniversary, celebrating decades of dedicated work in advancing Alzheimer's treatment and central nervous system (CNS) research. Established in 1976, this site has become a cornerstone in the greater Portland, Oregon area, contributing significantly to the development of groundbreaking medications and therapeutic interventions.

A Legacy of Impact

Since its inception, Headlands Summit has engaged in clinical trials that have propelled the pharmaceutical industry's understanding of a range of health conditions, particularly ones affecting mental health and neurology. The organization has played a crucial role in every FDA-approved class of Alzheimer's medication introduced to the market since 1993. Kyle Burtnett, CEO of Headlands Research, emphasizes the organization's commitment to improving the lives of patients and their families. He said, "Our fifty years of history and our contributions to Alzheimer's therapy have created a lasting legacy of impact."

Contributions to Alzheimer's Research

Under the leadership of Dr. Scott Losk, a seasoned clinical and neuropsychologist who has been with Headlands Summit since 1990, the organization has overseen more than 75 Alzheimer's clinical trials, shaping the paths to medication approval. The trials have involved a diverse array of treatments, including acetylcholinesterase inhibitors like donepezil, NMDA receptor antagonists like memantine, and newer anti-amyloid therapies such as aducanumab and lecanemab. Dr. Losk highlights how the commitment to advancing research has remained steadfast throughout the organization’s history.

"Our mission has always been clear: to enhance the quality of life for patients and families grappling with Alzheimer's and related disorders," he stated. This resolute focus has allowed Headlands Summit to stay at the forefront of significant medical innovations.

Expanding Horizons

In recent years, the clinical research landscape has evolved to address a more diverse range of conditions. Currently, Headlands Summit extends its expertise beyond Alzheimer's and CNS disorders to include research in diabetes, obesity, and weight management, along with immunization studies. This diversification reflects their commitment to innovative methodologies that promote comprehensive health solutions.

Dr. Andre Barkhuizen, Principal Investigator at Headlands Summit, underscores the importance of these new research ventures. "We are dedicated to innovating in CNS research while also exploring new therapeutic areas, ensuring that we offer cutting-edge opportunities for the Portland community," he summarized.

Looking to the Future

The Memory Health Center, a dedicated program within Headlands Summit, zeroes in on age-related memory conditions, further affirming their standing as a leader in Alzheimer’s research. With nearly 500 clinical trials conducted in partnership with various pharmaceutical companies and CROs over the last fifty years, Headlands Summit is uniquely positioned to continue making significant contributions to medical science.

As the organization heads into the next decade, the commitment to pioneering research remains resolute. With a proven track record of successful trials and a research environment that prioritizes patient-centered care, Headlands Research - Summit Portland is excited to embrace new challenges and advance their mission of improving patient outcomes.

About Headlands Research

Headlands Research operates a network of clinical trials across multiple sites, focusing on creating innovative medical therapies that enhance the quality of healthcare. Their team comprises industry leaders with extensive expertise in various medical fields, allowing them to cater to diverse participant populations and deliver high-quality data. With its legacy firmly rooted in advancing medical knowledge, Headlands Research stands as a beacon of hope for countless patients and families facing health challenges. For more information, visit www.headlandsresearch.com.